Positive Results From Interferon-Free Phase 2 "Co-Pilot" Study For The Treatment Of Hepatitis C
Abbott and Enanta Pharmaceuticals announced data from "Co-Pilot," an interferon-free, Phase 2 study of Abbott's direct-acting antiviral medicines for the treatment of hepatitis C (HCV) that found…